Higher Viral Load Drives Infrequent Severe Acute Respiratory Syndrome Coronavirus 2 Transmission Between Asymptomatic Residence Hall Roommates.


Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
28 10 2021
Historique:
received: 31 03 2021
accepted: 22 07 2021
pubmed: 25 7 2021
medline: 9 11 2021
entrez: 24 7 2021
Statut: ppublish

Résumé

The coronavirus disease 2019 pandemic spread to >200 countries in <6 months. To understand coronavirus spread, determining transmission rate and defining factors that increase transmission risk are essential. Most cases are asymptomatic, but people with asymptomatic infection have viral loads indistinguishable from those in symptomatic people, and they do transmit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, asymptomatic cases are often undetected. Given high residence hall student density, the University of Colorado Boulder established a mandatory weekly screening test program. We analyzed longitudinal data from 6408 students and identified 116 likely transmission events in which a second roommate tested positive within 14 days of the index roommate. Although the infection rate was lower in single-occupancy rooms (10%) than in multiple-occupancy rooms (19%), interroommate transmission occurred only about 20% of the time. Cases were usually asymptomatic at the time of detection. Notably, individuals who likely transmitted had an average viral load approximately 6.5-fold higher than individuals who did not (mean quantification cycle [Cq], 26.2 vs 28.9). Although students with diagnosed SARS-CoV-2 infection moved to isolation rooms, there was no difference in time to isolation between cases with or without interroommate transmission. This analysis argues that interroommate transmission occurs infrequently in residence halls and provides strong correlative evidence that viral load is proportional to transmission probability.

Sections du résumé

BACKGROUND
The coronavirus disease 2019 pandemic spread to >200 countries in <6 months. To understand coronavirus spread, determining transmission rate and defining factors that increase transmission risk are essential. Most cases are asymptomatic, but people with asymptomatic infection have viral loads indistinguishable from those in symptomatic people, and they do transmit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, asymptomatic cases are often undetected.
METHODS
Given high residence hall student density, the University of Colorado Boulder established a mandatory weekly screening test program. We analyzed longitudinal data from 6408 students and identified 116 likely transmission events in which a second roommate tested positive within 14 days of the index roommate.
RESULTS
Although the infection rate was lower in single-occupancy rooms (10%) than in multiple-occupancy rooms (19%), interroommate transmission occurred only about 20% of the time. Cases were usually asymptomatic at the time of detection. Notably, individuals who likely transmitted had an average viral load approximately 6.5-fold higher than individuals who did not (mean quantification cycle [Cq], 26.2 vs 28.9). Although students with diagnosed SARS-CoV-2 infection moved to isolation rooms, there was no difference in time to isolation between cases with or without interroommate transmission.
CONCLUSIONS
This analysis argues that interroommate transmission occurs infrequently in residence halls and provides strong correlative evidence that viral load is proportional to transmission probability.

Identifiants

pubmed: 34302469
pii: 6327655
doi: 10.1093/infdis/jiab386
pmc: PMC8861368
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1316-1324

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM029090
Pays : United States

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Références

Am J Orthopsychiatry. 2009 Oct;79(4):491-9
pubmed: 20099940
Lancet Infect Dis. 2021 May;21(5):629-636
pubmed: 33545090
PLoS Biol. 2021 Jul 12;19(7):e3001333
pubmed: 34252080
Lancet Microbe. 2021 Jan;2(1):e13-e22
pubmed: 33521734
Proc Natl Acad Sci U S A. 2021 Mar 2;118(9):
pubmed: 33571106
JAMA Netw Open. 2020 Dec 1;3(12):e2031756
pubmed: 33315116
Nat Commun. 2021 Jun 16;12(1):3664
pubmed: 34135322
Sci Adv. 2021 Jan 1;7(1):
pubmed: 33219112
Wellcome Open Res. 2020 Apr 9;5:67
pubmed: 32685698
JAMA Netw Open. 2021 Jan 4;4(1):e2035057
pubmed: 33410879
Nature. 2020 Aug;584(7821):430-436
pubmed: 32640463
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114
JAMA Netw Open. 2021 Mar 1;4(3):e211085
pubmed: 33688964
JAMA Intern Med. 2020 Nov 1;180(11):1447-1452
pubmed: 32780793
Proc Natl Acad Sci U S A. 2021 May 25;118(21):
pubmed: 33972412
PLoS One. 2020 Dec 9;15(12):e0243597
pubmed: 33296437
J Health Econ. 2014 Jan;33:126-38
pubmed: 24316458
Nature. 2020 Aug;584(7821):425-429
pubmed: 32604404

Auteurs

Kristen K Bjorkman (KK)

BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, USA.

Tassa K Saldi (TK)

BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, USA.

Erika Lasda (E)

BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, USA.

Leisha Conners Bauer (LC)

Health Promotion, University of Colorado Boulder, Boulder, Colorado, USA.

Jennifer Kovarik (J)

Health Promotion, University of Colorado Boulder, Boulder, Colorado, USA.

Patrick K Gonzales (PK)

BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, USA.

Morgan R Fink (MR)

BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, USA.

Kimngan L Tat (KL)

BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, USA.

Cole R Hager (CR)

BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, USA.

Jack C Davis (JC)

BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, USA.
Department of Molecular, Cellular, and Developmental Biology, University of Colorado Boulder, Boulder, Colorado, USA.

Christopher D Ozeroff (CD)

BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, USA.
Department of Molecular, Cellular, and Developmental Biology, University of Colorado Boulder, Boulder, Colorado, USA.

Gloria R Brisson (GR)

Medical Services, University of Colorado Boulder, Boulder, Colorado, USA.

Daniel B Larremore (DB)

BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, USA.
Department of Computer Science, University of Colorado Boulder, Boulder, Colorado, USA.

Leslie A Leinwand (LA)

BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, USA.
Department of Molecular, Cellular, and Developmental Biology, University of Colorado Boulder, Boulder, Colorado, USA.

Matthew B McQueen (MB)

Department of Integrative Physiology, University of Colorado Boulder, Boulder, Colorado, USA.
Institute for Behavioral Genetics, University of Colorado Boulder, Boulder, Colorado, USA.

Roy Parker (R)

BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, USA.
Howard Hughes Medical Institute, University of Colorado Boulder, Boulder, Colorado, USA.
Department of Biochemistry, University of Colorado Boulder, Boulder, Colorado, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH